Baicalin inhibits the expression of monocyte chemoattractant protein-1 and interleukin-6 in the kidneys ofapolipoprotein E-knockout mice fed a high cholesterol diet

Molecular Medicine Reports

Volumn 11, Issue 5, 2015, Pages 3976-3980

  Liu, Lihua ^a   Liao, Pingping ^a   Wang, Bin ^a   Fang, Xin ^a   Li, Wei ^a   Guan, Siming ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Baicalin; Interleukin 6; Monocyte chemoattractant protein 1; Vascular cell adhesion molecule 1

Indexed keywords

APOLIPOPROTEIN E; BAICALIN; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1; CHOLESTEROL; FLAVONOID; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHOLESTEROL DIET; CONTROLLED STUDY; EXPERIMENTAL ATHEROSCLEROSIS; GENE EXPRESSION; KIDNEY DYSFUNCTION; KIDNEY PARENCHYMA; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RENAL PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING; WILD TYPE; ANIMAL; BLOOD; DEFICIENCY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; KIDNEY; KNOCKOUT MOUSE; LIPID DIET; METABOLISM;

MUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOLIPOPROTEINS E; CHEMOKINE CCL2; CHOLESTEROL; DIET, HIGH-FAT; FLAVONOIDS; GENE EXPRESSION REGULATION; INTERLEUKIN-6; KIDNEY; MALE; MICE; MICE, KNOCKOUT; RNA, MESSENGER; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84922295335     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3186     Document Type: Article

References (34)

1. Moorhead JF, Chan MK, El-Nahas M and Varghese Z: Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 2: 1309-1311, 1982.
2. uan XZ, Varghese Z and Moorhead JF: An update on the lipid nephrotoxicity hypothesis. Nat Rev Nephrol 5: 713-721, 2009.
3. Kim E, Tolhurst AT, Qin LY, Chen XY, Febbraio M and Cho S: CD36/fatty acid translocase, an inflammatory mediator, is involved in hyperlipidemia-induced exacerbation in ischemic brain injury. J Neurosci 28: 4661-4670, 2008.
4. Sultan A, Strodthoff D, Robertson AK, et al: T cell-mediated inflammation in adipose tissue does not cause insulin resistance in hyperlipidemic mice. Circ Res 104: 961-968, 2009.
5. Perez de Lema G, Maier H, Nieto E, et al: Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J Am Soc Nephrol 12: 1369-1382, 2001.
6. Anders HJ, Belemezova E, Eis V, et al: Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice. J Am Soc Nephrol 15: 1504-1513, 2004.
7. Rovin BH, Rumancik M, Tan L and Dickerson J: Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis. Lab Invest 71: 536-542, 1994.
8. Zoja C, Liu XH, Donadelli R, et al: Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune mice. J Am Soc Nephrol 8: 720-729, 1997.
9. Tesch GH, Schwarting A, Kinoshita K, Lan HY, Rollins BJ and Kelley VR: Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J Clin Invest 103: 73-80, 1999.
10. Chow F, Ozols E, Nikolic-Paterson DJ, Atkins RC and Tesch GH: Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int 65: 116-128, 2004.
11. He X, Schoeb TR, Panoskaltsis-Mortari A, et al: Deficiency of P-selectin or P-selectin glycoprotein ligand-1 leads to accelerated development of glomerulonephritis and increased expression of CC chemokine ligand 2 in lupus-prone mice. J Immunol 177: 8748-8756, 2006.
12. Tashiro K, Koyanagi I, Saitoh A, et al: Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy. J Clin Lab Anal 16: 1-4, 2002.
13. Kanamori H, Matsubara T, Mima A, et al: Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy. Biochem Biophys Res Commun 360: 772-777, 2007.
14. Chow FY, Nikolic-Paterson DJ, Ozols E, Atkins RC, Rollin BJ and Tesch GH: Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int 69: 73-80, 2006.
15. Garibotto G, Sofia A, Balbi M, et al: Kidney and splanchnic handling of interleukin-6 in humans. Cytokine 37: 51-54, 2007.
16. Li C, Lin G and Zuo Z: Pharmacological effects and pharmacokinetics properties of Radix scutellariae and its bioactive flavones. Biopharm Drug Dispos 32: 427-445, 2011.
17. Baylor NW, Fu T, Yan YD and Ruscetti FW: Inhibition of human T cell leukemia virus by the plant flavonoid baicalin (7-glucuronic acid, 5,6-dihydroxyflavone). J Infect Dis 165: 433-437, 1992.
18. Li BQ, Fu T, Dongyan Y, Mikovits JA, Ruscetti FW and Wang JM: Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry. Biochem Biophys Res Commun 276: 534-538, 2000.
19. Zeng Y, Song C, Ding X, Ji X, Yi L and Zhu K: Baicalin reduces the severity of experimental autoimmune encephalomyelitis. Braz J Med Biol Res 40: 1003-1010, 2007.
20. Zhang XP, Tian H, Wu DJ, et al: Pathological changes in multiple organs of rats with severe acute pancreatitis treated by baicalin and octreotide. Hepatobiliary Pancreat Dis Int 8: 85-92, 2009.
21. Zhang X, Tian H, Wu C, et al: Effect of baicalin on inflammatory mediator levels and microcirculation disturbance in rats with severe acute pancreatitis. Pancreas 38: 732-738, 2009.
22. Zwai M, Chen R, Li Z, et al: Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice. Circulation 112: 1636-1643, 2005.
23. Kim DH, Kim HK, Park S, et al: Short-term feeding of baicalin inhibits age-associated NF-kappaB activation. Mech Ageing Dev 127: 719-725, 2006.
24. Zhang Y, Gao Z, Liu J and Xu Z: Protective effects of baicalin and quercetin on an iron-overloaded mouse: comparison of liver, kidney and heart tissues. Nat Prod Res 25: 1150-1160, 2011.
25. Zhang XP, Tian H, Lai YH, et al: Protective effects and mechanisms of Baicalin and octreotide on renal injury of rats with severe acute pancreatitis. World J Gastroenterol 13: 5079-5089, 2007.
26. Lv SS, Liu G, Wang JP, et al: Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting macrophage infiltration. Int Immunopharmacol 17: 275-282, 2013.
27. Tesch GH, Maifert S, Schwarting A, Rollins BJ and Kelley VR: Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice. J Exp Med 190: 1813-1824, 1999.
28. Fu CP, Lee IT, Sheu WH, et al: The levels of circulating and urinary monocyte chemoattractant protein-1 are associated with chronic renal injury in obese men. Clin Chim Acta 413: 1647-1651, 2012.
29. Wu T, Xie C, Wang HW, et al: Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis. J Immunol 179: 7166-7175, 2007.
30. Bolton CH, Downs LG, Victory JG, et al: Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant 16: 1189-1197, 2001.
31. Cottone S, Mule G, Amato F, et al: Amplified biochemical activation of endothelial function in hypertension associated with moderate to severe renal failure. J Nephrol 15: 643-648, 2002.
32. Zhu L, Shi S, Liu L, Lv J and Zhang H: Increased plasma sVCAM-1 is associated with severity in IgA nephropathy. BMC Nephrol 14: 21, 2013.
33. Nelson CL, Karschimkus CS, Dragicevic G, et al: Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function. Nephrol Dial Transplant 20: 2420-2426, 2005.
34. Bruneval P, Bariety J, Belair MF, Mandet C, Heudes D and Nicoletti A: Mesangial expansion associated with glomerular endothelial cell activation and macrophage recruitment is developing in hyperlipidaemic apoE null mice. Nephrol Dial Transplant 17: 2099-2107, 2002.